254 related articles for article (PubMed ID: 19430532)
41. Analysis of an alternative human CD133 promoter reveals the implication of Ras/ERK pathway in tumor stem-like hallmarks.
Tabu K; Kimura T; Sasai K; Wang L; Bizen N; Nishihara H; Taga T; Tanaka S
Mol Cancer; 2010 Feb; 9():39. PubMed ID: 20167130
[TBL] [Abstract][Full Text] [Related]
42. Elevated expression of the stem cell marker CD133 associated with Line-1 demethylation in hepatocellular carcinoma.
Zhang C; Xu Y; Zhao J; Fan L; Jiang G; Li R; Ling Y; Wu M; Wei L
Ann Surg Oncol; 2011 Aug; 18(8):2373-80. PubMed ID: 21331808
[TBL] [Abstract][Full Text] [Related]
43. Oct-4A isoform is expressed in human cord blood-derived CD133 stem cells and differentiated progeny.
Howe M; Zhao J; Bodenburg Y; McGuckin CP; Forraz N; Tilton RG; Urban RJ; Denner L
Cell Prolif; 2009 Jun; 42(3):265-75. PubMed ID: 19438894
[TBL] [Abstract][Full Text] [Related]
44. CD133 and CD44 are universally overexpressed in GIST and do not represent cancer stem cell markers.
Chen J; Guo T; Zhang L; Qin LX; Singer S; Maki RG; Taguchi T; Dematteo R; Besmer P; Antonescu CR
Genes Chromosomes Cancer; 2012 Feb; 51(2):186-95. PubMed ID: 22076958
[TBL] [Abstract][Full Text] [Related]
45. Expression of neural stem cell surface marker CD133 in balloon cells of human focal cortical dysplasia.
Ying Z; Gonzalez-Martinez J; Tilelli C; Bingaman W; Najm I
Epilepsia; 2005 Nov; 46(11):1716-23. PubMed ID: 16302851
[TBL] [Abstract][Full Text] [Related]
46. Glioblastoma cells negative for the anti-CD133 antibody AC133 express a truncated variant of the CD133 protein.
Osmond TL; Broadley KW; McConnell MJ
Int J Mol Med; 2010 Jun; 25(6):883-8. PubMed ID: 20428792
[TBL] [Abstract][Full Text] [Related]
47. Cancer stem-like cells in human prostate carcinoma cells DU145: the seeds of the cell line?
Wei C; Guomin W; Yujun L; Ruizhe Q
Cancer Biol Ther; 2007 May; 6(5):763-8. PubMed ID: 17592251
[TBL] [Abstract][Full Text] [Related]
48. Prognostic impact of CD133 mRNA expression in 48 glioblastoma patients treated with concomitant radiochemotherapy: a prospective patient cohort at a single institution.
Metellus P; Nanni-Metellus I; Delfino C; Colin C; Tchogandjian A; Coulibaly B; Fina F; Loundou A; Barrie M; Chinot O; Ouafik L; Figarella-Branger D
Ann Surg Oncol; 2011 Oct; 18(10):2937-45. PubMed ID: 21479688
[TBL] [Abstract][Full Text] [Related]
49. The stem cell marker CD133 (prominin-1) is phosphorylated on cytoplasmic tyrosine-828 and tyrosine-852 by Src and Fyn tyrosine kinases.
Boivin D; Labbé D; Fontaine N; Lamy S; Beaulieu E; Gingras D; Béliveau R
Biochemistry; 2009 May; 48(18):3998-4007. PubMed ID: 19296573
[TBL] [Abstract][Full Text] [Related]
50. Chemoresistance of CD133+ cancer stem cells in laryngeal carcinoma.
Yang JP; Liu Y; Zhong W; Yu D; Wen LJ; Jin CS
Chin Med J (Engl); 2011 Apr; 124(7):1055-60. PubMed ID: 21542968
[TBL] [Abstract][Full Text] [Related]
51. Downregulation of Prominin 1/CD133 expression in colorectal cancer by NSAIDs following short-term preoperative treatment.
Lönnroth C; Andersson M; Nordgren S; Lundholm K
Int J Oncol; 2012 Jul; 41(1):15-23. PubMed ID: 22552364
[TBL] [Abstract][Full Text] [Related]
52. Limits of CD133 as a marker of glioma self-renewing cells.
Clément V; Dutoit V; Marino D; Dietrich PY; Radovanovic I
Int J Cancer; 2009 Jul; 125(1):244-8. PubMed ID: 19350631
[TBL] [Abstract][Full Text] [Related]
53. Fetal human hematopoietic stem cells can differentiate sequentially into neural stem cells and then astrocytes in vitro.
Hao HN; Zhao J; Thomas RL; Parker GC; Lyman WD
J Hematother Stem Cell Res; 2003 Feb; 12(1):23-32. PubMed ID: 12662433
[TBL] [Abstract][Full Text] [Related]
54. Proliferation characteristics of CD133+ cell population in colorectal cancer.
Yu D; Zhang Y; Zou Y; Qin J; Li X; Xiao H; Tao D; Hu J; Gong J
J Huazhong Univ Sci Technolog Med Sci; 2010 Dec; 30(6):751-6. PubMed ID: 21181366
[TBL] [Abstract][Full Text] [Related]
55. Partial biological characterization of cancer stem-like cell line (WJ(2)) of human glioblastoma multiforme.
Wang J; Wang X; Jiang S; Lin P; Zhang J; Wu Y; Xiong Z; Ren JJ; Yang H
Cell Mol Neurobiol; 2008 Nov; 28(7):991-1003. PubMed ID: 18350379
[TBL] [Abstract][Full Text] [Related]
56. Expression of CD133 correlates with differentiation of human colon cancer cells.
Feng HL; Liu YQ; Yang LJ; Bian XC; Yang ZL; Gu B; Zhang H; Wang CJ; Su XL; Zhao XM
Cancer Biol Ther; 2010 Feb; 9(3):216-23. PubMed ID: 20023382
[TBL] [Abstract][Full Text] [Related]
57. Glucose transporter-1 expression in CD133+ laryngeal carcinoma Hep-2 cells.
Chen XH; Bao YY; Zhou SH; Wang QY; Wei Y; Fan J
Mol Med Rep; 2013 Dec; 8(6):1695-700. PubMed ID: 24146103
[TBL] [Abstract][Full Text] [Related]
58. CD133+ adult human retinal cells remain undifferentiated in Leukaemia Inhibitory Factor (LIF).
Carter DA; Dick AD; Mayer EJ
BMC Ophthalmol; 2009 Feb; 9():1. PubMed ID: 19236693
[TBL] [Abstract][Full Text] [Related]
59. Characterization of colon cancer cells: a functional approach characterizing CD133 as a potential stem cell marker.
Schneider M; Huber J; Hadaschik B; Siegers GM; Fiebig HH; Schüler J
BMC Cancer; 2012 Mar; 12():96. PubMed ID: 22433494
[TBL] [Abstract][Full Text] [Related]
60. CD133 expression and identification of CD133/nestin positive cells in rhabdomyosarcomas and rhabdomyosarcoma cell lines.
Sana J; Zambo I; Skoda J; Neradil J; Chlapek P; Hermanova M; Mudry P; Vasikova A; Zitterbart K; Hampl A; Sterba J; Veselska R
Anal Cell Pathol (Amst); 2011; 34(6):303-18. PubMed ID: 22156015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
